Overview / Abstract: |
In this video-based interview, Dan Schuller, MD reviews emerging management and therapeutic models for PAH treatment. Dr. Schuller addresses adverse therapeutic events, strategies for complex PAH cases, and related clinical trial data for both current and emerging PAH therapies. He additionally discusses advanced-practice strategies related to PAH disease classification, risk stratification, and therapeutic selection criteria, especially for complex PAH cases. |
Expiration |
Aug 15, 2019 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME |
Format |
Webinar / Webcast / Video |
Credits / Hours |
.50 |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Dan Schuller, MD |
Sponsors / Supporters / Grant Providers |
This activity is supported by educational grants from Actelion Pharmaceuticals US, Inc., and Bayer HealthCare Pharmaceuticals Inc. |
Keywords / Search Terms |
ACHL PAH, PH, pulmonary, pulmonary hypertension, pulmonary arterial hypertension, pulmonologist, patient, case study, case, dan schuller, schuller, Novel Therapeutic Options, Complex Case, Emerging Research, Shared Decision making, Improved Patient Participation, Strategies, Community, Specialist Practitioners, Specialist, strategy, improve; complex PH; mixed PH; complex and mixed PH Free CE CME |